The Digitome: a platform for enabling rapid decentralization, personalization and recruitment for clinical trials | eyeforpharma

FREE WEBINAR | November 12th, 2019

3pm London / 4pm Paris / 10am New York / 7am San Francisco

“Today, medicines work well in only a fraction of a target patient population. Not only is this a disservice to hundreds of thousands of patients, it is also a huge contributing factor to the poor performance and failure of many clinical trials.”

In Partnership With:

This is going to be an interesting discussion regarding #DigitalClinincalTrials, #DigitalTrials.

Discover the algorithms that canvass different datasets to help find the necessary unique patient populations’ with the aim of creating personalised trials.

You can find out how to virtually connect eligible patients for pre-screening’ as well as how to use ‘telemedicine to further reduce on-site screening failures‘.

Learn how to ‘improve trial design, site selection and predict results‘ through using ‘Machine Learning‘ – adjust your inclusion and exclusion criteria accordingly.

The big picture: a new trend in the use of digital biomarkers to build a picture of your own unique homeostasis and relying on technology to determine when deviations need attention

Discover the #algorithms that ‘canvass different #datasets’ to help find the necessary ‘unique #patientpopulations’ with the aim of creating #personalisedtrials. @eyeforpharma webinar #digitaltrials

Panelists include:

  • Michelle Longmire | CEO – Medable

  • Adama Ibrahim | Associate Director, POC, Global Clinical Operations – Biogen

Moderator: Paul Simms Chairman – eyeforpharma

Sign up now to be part of a very exciting session!

Learn how to ‘improve #trialdesign, site selection and #predictresults’ through using ‘#MachineLearning’ – adjust your inclusion and exclusion criteria accordingly. @eyeforpharma webinar #digitaltrials

eyeforpharma Ltd by Reuters Events, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909.

FibroFlutters supporting eyeforpharma by Reuters as Patient, Health, Research & Pharma advocates, we are non-commercial.

Author FibroFlutters Logo are proud to be actively supporting the work of AIMed Embracing #AI in #Healthcare #Medicine.

FibroFlutters Information banner
FibroFlutters Information banner

We are a Patient Advocacy Organisation & online social media communications network

FibroFlutters patient, health, clinical research, medical, pharma, digital health & AI advocacy.
Support and advice for people with chronic illnesses and rare disorders. Including, Pigmented Villondular Synovitis (PVNS), Ehlers-Danlos Syndrome (EDS), Hypermobility Spectrum Disorders (HSD’s), Fibromyalgia, Chronic pain disorders, Musculoskeletal conditions, Chronic Fatigue Syndromes / ME, and Mental Health.

We also have a Social media network for connecting multi-stakeholders from across the medical healthcare industries. It also provides us with a network for sharing information such as the latest research, news and events from a cross-section of areas within the medical healthcare industry.

We also have many other groups/pages/profiles across social media that we use to achieve our aims of Patient, Health, Research and Pharma Advocacy. They also give us the ability to provide advice and offer a friendly hand of support across many social media platforms. 

SLOGAN: #chronicillnessVOICE for everyone #notjustpatients


  • We are not medical professionals nor claim to be. Remember that you should always consult your doctor about any health problems and not solely rely on Dr Google, or on any information that you may read online through 3rd parties.
  • That this site uses google analytics to collect demographic information for content decision making purposes only and not to sell to 3rd parties.

Its A Doddle – Mapping the communities that care

By Mapping UK Charities, Community Projects, Groups & Organisations together we are creating a national resource for use at a local level. Check out our profile via this button below.

SYNAPSE / Patient Focused Medicines Development (PFMD) joined in 2019

Check out our profile to see what initiatives we’re involved in, what the work will involve and how diverse a group of people that we are collaborating with on improving patient engagement within clinical trials. Very different! Very exciting! Very Grateful!

Got something to share then don’t hesitate to get in touch with us. Also if you want to write for me in exchange for publishing privileges let me know via the e-mail link below.

FibroFlutters are continuously

Advocating for a Multi-Disciplinary approach to all aspects of medical healthcare. 
Using a model approach using all the ‘stakeholders’ and a patient’s perspective of what patient-centred care, patient-included, patient-involved, patient-centric should look like and involve, that’s everyone by the way!
You all need to pitch in!!

Please note that I have opted-in to receive all the newsletters that I post from. PLUS please remember to read their privacy policies.  

Please can you read our ‘Disclaimer’ & ‘Privacy’ notes. If you have any problems we are always open to discussion, just e-mail Carole

FibroFlutters ~ CHRONIC, INVISIBLE AND RARE ILLNESS SUPPORT / ADVICE / ADVOCACY| Disclaimer | Privacy Notes | 8 May 2018